minoxidil has been researched along with cyclosporine in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (10.53) | 18.2507 |
2000's | 4 (21.05) | 29.6817 |
2010's | 12 (63.16) | 24.3611 |
2020's | 1 (5.26) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hozumi, Y; Imaizumi, T; Kondo, S | 1 |
Allen-Hoffmann, BL; Kurata, S; Uno, H | 1 |
Fatkin, D; Giewat, M; McConnell, BK; Moskowitz, IG; Mudd, JO; Schoen, FJ; Seidman, CE; Seidman, JG; Semsarian, C | 1 |
Kamiya, T; Shirai, A; Tamaoki, T; Tsunoda, H | 1 |
Alkhalifah, A; Alsantali, A; McElwee, KJ; Shapiro, J; Wang, E | 1 |
Jung, HD; Kang, H; Kim, JE | 1 |
Shapiro, J | 1 |
Perera, E; Sinclair, R; Yip, L | 1 |
Anderson, ZT; Cowart, J; Harris, ML; Idris, MI; Le, G; Palmer, JW; Villavicencio, KM; Weinstein, DE | 1 |
5 review(s) available for minoxidil and cyclosporine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropanes; Cyclosporine; Hair; Haptens; Humans; Immunotherapy; Injections, Intralesional; Laser Therapy; Methotrexate; Minoxidil; Photochemotherapy; Randomized Controlled Trials as Topic; Rats; Recurrence; Research Design; Social Support; Sulfasalazine; Treatment Outcome; Triamcinolone Acetonide | 2010 |
Current treatment of alopecia areata.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Alopecia Areata; Anthralin; Cyclobutanes; Cyclopropanes; Cyclosporine; Dermatologic Agents; Humans; Immunosuppressive Agents; Injections, Intralesional; Methotrexate; Minoxidil; PUVA Therapy; Self-Help Groups | 2013 |
Alopecia areata.
Topics: Administration, Topical; Adrenal Cortex Hormones; Alopecia Areata; Anthralin; Autoimmunity; Cyclopropanes; Cyclosporine; Dermatitis, Allergic Contact; Dermatologic Agents; Humans; Immunosuppressive Agents; Immunotherapy; Injections, Intralesional; Minoxidil; Vasodilator Agents | 2015 |
Drug-induced excess hair growth.
Topics: Adrenal Cortex Hormones; Androgens; Anticonvulsants; Cyclosporine; Dinoprost; ErbB Receptors; Hirsutism; Humans; Hypertrichosis; Immunosuppressive Agents; Minoxidil; Oxytocics; Phenytoin; Protein Kinase Inhibitors; Vasodilator Agents | 2017 |
14 other study(ies) available for minoxidil and cyclosporine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effect of cyclosporin on hair-existing area of nude mice.
Topics: Administration, Topical; Animals; Betamethasone Valerate; Cyclosporine; Drug Interactions; Estradiol; Female; Hair; Mice; Mice, Inbred BALB C; Mice, Nude; Minoxidil; Testosterone | 1994 |
Effects of hypertrichotic agents on follicular and nonfollicular cells in vitro.
Topics: 3T3 Cells; Animals; Cell Division; Cells, Cultured; Cyclosporine; DNA; Epithelial Cells; Epithelium; Female; Hair; Hair Follicle; Humans; Kinetics; Macaca; Male; Mice; Minoxidil; Thymidine | 1996 |
An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy.
Topics: Animals; Calcineurin Inhibitors; Calcium; Cardiomyopathy, Hypertrophic; Cyclosporine; Echocardiography; Enzyme Inhibitors; Heart Ventricles; Mice; Minoxidil; Mutation; Myosin Heavy Chains; Sarcomeres; Survival Analysis; Tacrolimus | 2000 |
Topical application of cyclosporin A induces rapid-remodeling of damaged anagen hair follicles produced in cyclophosphamide administered mice.
Topics: Administration, Topical; Alopecia; Animals; Antineoplastic Agents, Alkylating; Cyclophosphamide; Cyclosporine; Dermatologic Agents; Hair; Hair Follicle; Male; Mice; Mice, Inbred C3H; Minoxidil | 2001 |
Short anagen syndrome successfully controlled with topical minoxidil and systemic cyclosporine A combination therapy.
Topics: Administration, Topical; Cyclosporine; Drug Therapy, Combination; Fingers; Hair; Hair Diseases; Hair Follicle; Humans; Male; Minoxidil; Young Adult | 2011 |
Topical RT1640 treatment effectively reverses gray hair and stem cell loss in a mouse model of radiation-induced canities.
Topics: Administration, Topical; Animals; Cyclosporine; Dermatologic Agents; Disease Models, Animal; Drug Combinations; Female; Gamma Rays; Hair Color; Hair Diseases; Male; Melanins; Melanocytes; Mice; Mice, Inbred C57BL; Minoxidil; Pigmentation Disorders; Stem Cells; Vasodilator Agents | 2021 |